Host: Nicolas Girard, MD

Guest: Louise Lim, MD

Guest: Jacob Sands, MD

Guest: Stephanie McDonald, MSN, FNP-BC, AOCNP

You can now access the on-demand resources from a virtual Experts Knowledge Share on the evolving TROP2-directed antibody-drug conjugate (ADC) landscape in metastatic non-small cell lung cancer (NSCLC) and strategies to optimise the treatment experience.

Renowned experts Prof. Nicolas Girard (France), Dr Louise Lim (UK), Dr Jacob Sands (US), and Mrs Stephanie McDonald (US) discuss the following topics:

  • The relevance of TROP2 in metastatic NSCLC
  • Clinical overview of TROP2-directed ADCs in NSCLC:
    • With/without actionable genomic alterations
  • Optimising the treatment experience: proactive monitoring and management of adverse events
  • Best practice management: panel discussion and audience questions

Watch the video replay, or navigate to the conversation highlights or the accompanying slides.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör ReachMD. Innehållet i podden är skapat av ReachMD och inte av, eller tillsammans med, Poddtoppen.